Literature DB >> 15081148

Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.

Kathleen Dillen1, Jo Vandervoort, Guy Van den Mooter, Loes Verheyden, Annick Ludwig.   

Abstract

Poly(lactide-co-glycolide) nanoparticles incorporating ciprofloxacin HCl were prepared by means of a W/O/W emulsification solvent evaporation method. The stabiliser selected was poly(vinylalcohol). A 2(4) full factorial design based on four independent variables was used to plan the experiments and the variable parameters were the number of homogenisation cycles, addition of boric acid to the inner water phase containing the drug, ciprofloxacin concentration in the inner water phase and oil:outer water phase ratio. The effects of these parameters on the particle size, zeta potential, drug loading efficiency and drug release were investigated. Also the effect of gamma irradiation on the particle size and drug release was evaluated and DSC and XRD analyses of the compounds and the nanoparticles were performed. The activity on two series of microorganisms, Pseudomonas aeruginosa and Staphylococcus aureus, was examined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081148     DOI: 10.1016/j.ijpharm.2004.01.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

1.  A Design of Experiment Study of Nanoprecipitation and Nano Spray Drying as Processes to Prepare PLGA Nano- and Microparticles with Defined Sizes and Size Distributions.

Authors:  Christina Draheim; Francois de Crécy; Steffi Hansen; Eva-Maria Collnot; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-02-13       Impact factor: 4.200

2.  Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity.

Authors:  Corbin Clawson; Chien-Tze Huang; Diahnn Futalan; Daniel Martin Seible; Rebecca Saenz; Marie Larsson; Wenxue Ma; Boris Minev; Fiona Zhang; Mihri Ozkan; Cengiz Ozkan; Sadik Esener; Davorka Messmer
Journal:  Nanomedicine       Date:  2010-03-27       Impact factor: 5.307

Review 3.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

4.  Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying.

Authors:  Elzaan Booysen; Martin Bezuidenhout; Anton Du Preez van Staden; Dimiter Dimitrov; Shelly M Deane; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

5.  Poly (vinyl alcohol)/poly (acrylamide-co-diallyldimethyl ammonium chloride) semi-IPN hydrogels for ciprofloxacin hydrochloride drug delivery.

Authors:  Siva Sankar Sana; Vijaya Kumar Naidu Boya
Journal:  IET Nanobiotechnol       Date:  2017-02       Impact factor: 1.847

6.  Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.

Authors:  Ayse Nur Oktay; Sibel Ilbasmis-Tamer; Orhan Uludag; Nevin Celebi
Journal:  Pharm Res       Date:  2021-06-04       Impact factor: 4.200

7.  Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.

Authors:  Lydia A Hanna; Emad B Basalious; Omaima N ELGazayerly
Journal:  Drug Deliv       Date:  2016-11       Impact factor: 6.419

Review 8.  Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.

Authors:  R Dinarvand; N Sepehri; S Manoochehri; H Rouhani; F Atyabi
Journal:  Int J Nanomedicine       Date:  2011-05-27

9.  Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride.

Authors:  M Shah; Y K Agrawal; K Garala; A Ramkishan
Journal:  Indian J Pharm Sci       Date:  2012-09       Impact factor: 0.975

10.  Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design.

Authors:  Aviral Jain; Sanjay K Jain
Journal:  Biomatter       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.